肾移植中的免疫抑制

C. Legendre (Professeur des Universités, praticien hospitalier), J. Zuber (Chef de clinique-assistant), D. Anglicheau (Chef de clinique-assistant), M. Le Quintrec (Chef de clinique-assistant), F. Martinez (Praticien hospitalier), M.-F. Mamzer-Bruneel (Praticien hospitalier), E. Thervet (Professeur des Universités, praticien hospitalier)
{"title":"肾移植中的免疫抑制","authors":"C. Legendre (Professeur des Universités, praticien hospitalier),&nbsp;J. Zuber (Chef de clinique-assistant),&nbsp;D. Anglicheau (Chef de clinique-assistant),&nbsp;M. Le Quintrec (Chef de clinique-assistant),&nbsp;F. Martinez (Praticien hospitalier),&nbsp;M.-F. Mamzer-Bruneel (Praticien hospitalier),&nbsp;E. Thervet (Professeur des Universités, praticien hospitalier)","doi":"10.1016/j.anuro.2007.08.006","DOIUrl":null,"url":null,"abstract":"<div><p>Kidney transplantation has become the treatment of choice in end-stage chronic renal failure since it significantly improves both the quality of life and the life duration of affected patients, when compared with dialysis. Some of these better results that were observed over the last thirty years are obviously due to significant improvements in the quality of immunosuppression. In the first part of this chapter, the allo-immune response is schematically described regarding the various signals. Then, the mechanisms of action of the available or future immunosuppressive therapies are described in the same order as the allo-immune response. In the third part, the various combinations of immunosuppressive regimens are presented from a historical perspective, outlining not only the positive aspects of each class of drugs but also their side effects and consequences on the practical use of immunosuppression over time. Finally, a brief review of current and future perspectives regarding the improvement of both efficacy and tolerability of immunosuppression in kidney transplantation is presented.</p></div>","PeriodicalId":50783,"journal":{"name":"Annales D Urologie","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.anuro.2007.08.006","citationCount":"9","resultStr":"{\"title\":\"Immunosuppression en transplantation rénale\",\"authors\":\"C. Legendre (Professeur des Universités, praticien hospitalier),&nbsp;J. Zuber (Chef de clinique-assistant),&nbsp;D. Anglicheau (Chef de clinique-assistant),&nbsp;M. Le Quintrec (Chef de clinique-assistant),&nbsp;F. Martinez (Praticien hospitalier),&nbsp;M.-F. Mamzer-Bruneel (Praticien hospitalier),&nbsp;E. Thervet (Professeur des Universités, praticien hospitalier)\",\"doi\":\"10.1016/j.anuro.2007.08.006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Kidney transplantation has become the treatment of choice in end-stage chronic renal failure since it significantly improves both the quality of life and the life duration of affected patients, when compared with dialysis. Some of these better results that were observed over the last thirty years are obviously due to significant improvements in the quality of immunosuppression. In the first part of this chapter, the allo-immune response is schematically described regarding the various signals. Then, the mechanisms of action of the available or future immunosuppressive therapies are described in the same order as the allo-immune response. In the third part, the various combinations of immunosuppressive regimens are presented from a historical perspective, outlining not only the positive aspects of each class of drugs but also their side effects and consequences on the practical use of immunosuppression over time. Finally, a brief review of current and future perspectives regarding the improvement of both efficacy and tolerability of immunosuppression in kidney transplantation is presented.</p></div>\",\"PeriodicalId\":50783,\"journal\":{\"name\":\"Annales D Urologie\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.anuro.2007.08.006\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annales D Urologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0003440107000708\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales D Urologie","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0003440107000708","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 9

摘要

肾移植已成为终末期慢性肾功能衰竭的治疗选择,因为与透析相比,肾移植可显著改善患者的生活质量和生存时间。在过去三十年中观察到的一些较好的结果显然是由于免疫抑制质量的显著提高。在本章的第一部分,同种免疫反应是关于各种信号的概要描述。然后,现有的或未来的免疫抑制疗法的作用机制是按照同种免疫反应的顺序描述的。在第三部分中,从历史的角度介绍了各种免疫抑制方案的组合,不仅概述了每一类药物的积极方面,而且还概述了它们的副作用和随着时间的推移对免疫抑制实际使用的后果。最后,简要回顾了目前和未来关于提高肾移植中免疫抑制的疗效和耐受性的观点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Immunosuppression en transplantation rénale

Kidney transplantation has become the treatment of choice in end-stage chronic renal failure since it significantly improves both the quality of life and the life duration of affected patients, when compared with dialysis. Some of these better results that were observed over the last thirty years are obviously due to significant improvements in the quality of immunosuppression. In the first part of this chapter, the allo-immune response is schematically described regarding the various signals. Then, the mechanisms of action of the available or future immunosuppressive therapies are described in the same order as the allo-immune response. In the third part, the various combinations of immunosuppressive regimens are presented from a historical perspective, outlining not only the positive aspects of each class of drugs but also their side effects and consequences on the practical use of immunosuppression over time. Finally, a brief review of current and future perspectives regarding the improvement of both efficacy and tolerability of immunosuppression in kidney transplantation is presented.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Annales D Urologie
Annales D Urologie 医学-泌尿学与肾脏学
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信